S&P 500 Futures
(0.06%) 5 311.50 points
Dow J Futures
(0.07%) 40 173 points
Nasdaq Futures
(0.10%) 18 523 points
Oil
(1.68%) $82.72
Gas
(0.12%) $1.720
Gold
(0.85%) $2 231.50
Silver
(-0.08%) $24.73
Platinum
(0.49%) $914.20
USD/EUR
(0.33%) $0.926
USD/NOK
(0.57%) $10.83
USD/GBP
(0.10%) $0.792
USD/RUB
(-0.08%) $92.37

Realtime updates for DICE Therapeutics, Inc. [DICE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated8 Aug 2023 @ 16:00

0.06% $ 47.55

Live Chart Being Loaded With Signals

Commentary (8 Aug 2023 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas...

Stats
Today's Volume 4.33M
Average Volume 1.75M
Market Cap 2.27B
EPS $0 ( 2024-03-14 )
Next earnings date ( $0 ) 2024-05-10
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -21.91
ATR14 $0.513 (1.08%)
Insider Trading
Date Person Action Amount type
2023-08-09 Ra Capital Management, L.p. Sell 786 407 Common Stock
2023-08-09 Ra Capital Management, L.p. Sell 21 250 Stock Option (Right to Buy)
2023-08-09 Tetlow Sharon Sell 49 841 Common Stock
2023-08-09 Tetlow Sharon Sell 13 800 Stock Option (right to buy)
2023-08-09 Tetlow Sharon Sell 21 250 Stock Option (right to buy)
INSIDER POWER
-53.87
Last 99 transactions
Buy: 13 025 781 | Sell: 10 716 392

Volume Correlation

Long: 0.25 (neutral)
Short: 0.00 (neutral)
Signal:(77.583) Neutral

DICE Therapeutics, Inc. Correlation

10 Most Positive Correlations
MRNS0.883
DGNU0.879
ABCM0.863
ABEO0.86
SKYW0.86
SINO0.859
FSFG0.858
CGNT0.858
DFH0.855
IRBT0.851
10 Most Negative Correlations
WYNN-0.869
MCFT-0.869
LIBY-0.867
LSCC-0.866
ASUR-0.865
TGLS-0.864
ULTA-0.863
KYCH-0.863
ARYD-0.863
LAKE-0.863

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DICE Therapeutics, Inc. Correlation - Currency/Commodity

The country flag 0.18
( neutral )
The country flag -0.14
( neutral )
The country flag 0.41
( neutral )
The country flag 0.48
( neutral )
The country flag -0.06
( neutral )
The country flag -0.81
( strong negative )

DICE Therapeutics, Inc. Financials

Annual 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-2.07
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.740
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.420
Q4 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.500

Financial Reports:

No articles found.

DICE Therapeutics, Inc.

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. In addition, the company focuses on immuno-oncology for antibody therapeutics. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators